Zitvogel L - Search Results

1

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.

Ferrere G, Tidjani Alou M, Liu P, Goubet AG, Fidelle M, Kepp O, Durand S, Iebba V, Fluckiger A, Daillère R, Thelemaque C, Grajeda-Iglesias C, Alves Costa Silva C, Aprahamian F, Lefevre D, Zhao L, Ryffel B, Colomba E, Arnedos M, Drubay D, Rauber C, Raoult D, Asnicar F, Spector T, Segata N, Derosa L, Kroemer G, Zitvogel L. Ferrere G, et al. Among authors: zitvogel l. JCI Insight. 2021 Jan 25;6(2):e145207. doi: 10.1172/jci.insight.145207. JCI Insight. 2021. PMID: 33320838 Free PMC article.

2

Immune response against dying tumor cells.

Zitvogel L, Casares N, Péquignot MO, Chaput N, Albert ML, Kroemer G. Zitvogel L, et al. Adv Immunol. 2004;84:131-79. doi: 10.1016/S0065-2776(04)84004-5. Adv Immunol. 2004. PMID: 15246252 Review. No abstract available.

3

Cancer despite immunosurveillance: immunoselection and immunosubversion.

Zitvogel L, Tesniere A, Kroemer G. Zitvogel L, et al. Nat Rev Immunol. 2006 Oct;6(10):715-27. doi: 10.1038/nri1936. Epub 2006 Sep 15. Nat Rev Immunol. 2006. PMID: 16977338 Review.

4

The immune system: taming and unleashing cancer.

Tesniere A, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: zitvogel l. Discov Med. 2006 Dec;6(36):211-6. Discov Med. 2006. PMID: 17250785 Free article.

5

Links between innate and cognate tumor immunity.

Ghiringhelli F, Apetoh L, Housseau F, Kroemer G, Zitvogel L. Ghiringhelli F, et al. Among authors: zitvogel l. Curr Opin Immunol. 2007 Apr;19(2):224-31. doi: 10.1016/j.coi.2007.02.003. Epub 2007 Feb 15. Curr Opin Immunol. 2007. PMID: 17303400 Review.

6

Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis.

Castedo M, Coquelle A, Vitale I, Vivet S, Mouhamad S, Viaud S, Zitvogel L, Kroemer G. Castedo M, et al. Among authors: zitvogel l. Ann N Y Acad Sci. 2006 Dec;1090:35-49. doi: 10.1196/annals.1378.004. Ann N Y Acad Sci. 2006. PMID: 17384245

7

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, André F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Apetoh L, et al. Among authors: zitvogel l. Nat Med. 2007 Sep;13(9):1050-9. doi: 10.1038/nm1622. Epub 2007 Aug 19. Nat Med. 2007. PMID: 17704786

8

Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.

Obeid M, Panaretakis T, Tesniere A, Joza N, Tufi R, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Obeid M, et al. Among authors: zitvogel l. Cancer Res. 2007 Sep 1;67(17):7941-4. doi: 10.1158/0008-5472.CAN-07-1622. Cancer Res. 2007. PMID: 17804698 Review.

9

Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.

Apetoh L, Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Piacentini M, Kroemer G, Zitvogel L. Apetoh L, et al. Among authors: zitvogel l. Cancer Genomics Proteomics. 2007 Mar-Apr;4(2):65-70. Cancer Genomics Proteomics. 2007. PMID: 17804868 Free article. Review.

10

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.

Chaput N, De Botton S, Obeid M, Apetoh L, Ghiringhelli F, Panaretakis T, Flament C, Zitvogel L, Kroemer G. Chaput N, et al. Among authors: zitvogel l. J Mol Med (Berl). 2007 Oct;85(10):1069-76. doi: 10.1007/s00109-007-0214-1. Epub 2007 May 22. J Mol Med (Berl). 2007. PMID: 17891368 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page